Antibiotics are overused by some and out of reach for others - fuelling resistance and leaving deadly gaps in care.

The OxStu discusses the causes and implications of antimicrobial resistance, and the social and scientific methods to combat ...

UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and ...

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Stat: A Case Study In The Fast-Rising Threat Of Antibiotic Resistance In the good old days — way back in early 2012 — people who contracted gonorrhea were given a single pill to cure the infection. A ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing. Swiss ...

The urinary tract infection (UTI) treatment market is estimated to be valued at USD 11.24 billion in 2024. The scope for urinary tract infection (UTI) treatment is predicted to rise at a CAGR of 1.9% ...